Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Statins for children with familial hypercholesterolemia.

Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Strandberg T, Tonstad S, Gylling H.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD006401. doi: 10.1002/14651858.CD006401.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD006401.

PMID:
20614444
2.

Statins for children with familial hypercholesterolemia.

Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E.

Cochrane Database Syst Rev. 2014 Jul 23;(7):CD006401. doi: 10.1002/14651858.CD006401.pub3. Review.

PMID:
25054950
3.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

4.

Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock EP.

JAMA. 2016 Aug 9;316(6):645-55. doi: 10.1001/jama.2016.6176. Review.

PMID:
27532919
5.

Low-density lipoprotein apheresis: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2007;7(5):1-101.

6.

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, Blasi P, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Aug.

7.

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.

Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, Sijbrands EJ, Kastelein JJ.

JAMA. 2004 Jul 21;292(3):331-7.

PMID:
15265847
8.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group..

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
9.

Lipid-lowering agents for nephrotic syndrome.

Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.

Cochrane Database Syst Rev. 2013 Dec 10;(12):CD005425. doi: 10.1002/14651858.CD005425.pub2. Review.

PMID:
24327265
10.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD005019. doi: 10.1002/14651858.CD005019.pub4. Review.

PMID:
24470059
11.

Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials.

Lebenthal Y, Horvath A, Dziechciarz P, Szajewska H, Shamir R.

Arch Dis Child. 2010 Sep;95(9):673-80. doi: 10.1136/adc.2008.157024. Review.

PMID:
20515970
12.

The spectrum of statin therapy in hyperlipidemic children.

Rodenburg J, Vissers MN, Trip MD, Wiegman A, Bakker HD, Kastelein JJ.

Semin Vasc Med. 2004 Nov;4(4):313-20. Review.

PMID:
15861313
13.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2013 Sep 11;(9):CD004289. doi: 10.1002/14651858.CD004289.pub5. Review.

PMID:
24022428
14.

Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.

Malhotra A, Shafiq N, Arora A, Singh M, Kumar R, Malhotra S.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD001918. doi: 10.1002/14651858.CD001918.pub3. Review.

PMID:
24913720
15.
16.

Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability.

Carreau V, Girardet JP, Bruckert E.

Paediatr Drugs. 2011 Aug 1;13(4):267-75. doi: 10.2165/11591650-000000000-00000.

PMID:
21692550
17.

Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.

Avis HJ, Hutten BA, Gagné C, Langslet G, McCrindle BW, Wiegman A, Hsia J, Kastelein JJ, Stein EA.

J Am Coll Cardiol. 2010 Mar 16;55(11):1121-6. doi: 10.1016/j.jacc.2009.10.042.

18.

A meta-analysis to evaluate the efficacy of statins in children with familial hypercholesterolemia.

Shafiq N, Bhasin B, Pattanaik S, Pandhi P, Venkateshan SP, Singh M, Malhotra S.

Int J Clin Pharmacol Ther. 2007 Oct;45(10):548-55. Erratum in: Int J Clin Pharmacol Ther. 2008 Jan;46(1):41.

PMID:
17966840
19.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 May 31;(5):CD007784. doi: 10.1002/14651858.CD007784.pub2. Review.

PMID:
24880031
20.

Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects.

O'Gorman CS, Higgins MF, O'Neill MB.

Pediatr Cardiol. 2009 May;30(4):482-9. doi: 10.1007/s00246-008-9364-3. Review.

PMID:
19189168
Items per page

Supplemental Content

Support Center